After matching, baseline characteristics between cohorts were well balanced in mean age (47.6 vs
It's important to note that Ozempic (semaglutide) is licensed specifically for type 2 diabetes treatment, while Wegovy (also semaglutide but at different doses) is licensed for weight management
The mechanism of GHK-Cu differs fundamentally from both Retatrutide and the healing peptides discussed previously
These findings point to a central mechanismbeyond weight loss and blood sugar controlwhere GLP1 medicines are acting directly on the brain to support cognition, mood, and neural health
PLoS ONE (2017) 12:e0186033
The decision to use both medications concurrently should always be made by your prescribing doctor , who will consider your complete medical history, current health status, and treatment goals